Cellebrite DI (NASDAQ:CLBT – Free Report) had its target price upped by Needham & Company LLC from $13.50 to $14.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. A number of other equities analysts also recently issued reports on CLBT. Craig […]

Related Keywords

United States , New York , America , Zurcher Kantonalbank Zurich Cantonalbank , Craig Hallum , William Blair , Central Asset Investments Management Holdings Hk Ltd , Cellebrite Di Ltd , Needham Company , York State Common Retirement Fund , Free Report , Lake Street Capital , Get Free Report , Asset Investments , Management Holdings , Kantonalbank Zurich Cantonalbank , New York State Common Retirement Fund , Middle East ,